Quote:

---

I'm surprised we didn't get a PR about this new pharma agreement. Perhaps they're planning one for tomorrow and Ajinomoto got out ahead of them a day earlier than expected.

---

They were already working with Ajinimoto (filling services for vials), I would say with AGC biologics production in small amounts.

As per PR it reads:

Ajinimoto: "is pleased to announce it has entered into a manufacturing services agreement with CytoDyn Inc." and ""Aji Bio-Pharma provides high quality drug product aseptic fill finish services for CytoDyn."

Dr. Pourhassan: "We are extremely pleased to already have been collaborating with Aji Bio-Pharma for the production of leronlimab for other therapeutic indications, allowing us to quickly provide this therapeutic to COVID-19 patients in clinical trials,"

Might in future there will come more out of this partnership, we will see.